Keyphrases
Indonesia
100%
Surabaya
82%
Escherichia Coli
41%
Culture Method
26%
Risk Factors
24%
Gram-negative Bacteria
23%
Whole-genome Sequence Data
22%
Decontamination
21%
Positive Culture
21%
Extended-spectrum-lactamase
21%
Japan
21%
Klebsiella Pneumoniae (K. pneumoniae)
20%
Microbiology
19%
Sputum Decontamination
19%
Podocyte
19%
Apoptosis-inducing Factor
19%
Glutamine
19%
Cisplatin
19%
Mycobacterium Culture
19%
Lowenstein-Jensen
19%
Mupirocin
19%
Critical Priority
19%
Hidden Danger
19%
Blood Isolates
19%
Antibiotic Resistance Index
19%
Multiple Antibiotic Resistance
19%
Laboratory-confirmed Bloodstream Infection
19%
Enterobacteriaceae
19%
Effectiveness Comparison
19%
Urinary Tract Infection
19%
Protein Expression
19%
Antibiotic Resistance
19%
International Comparison
19%
Fluoroquinolone Resistance
19%
Salmonella Enterica
19%
Mycobacterium Tuberculosis (M. tb)
19%
Biofilm
19%
Kobe
19%
Streptococcus Pneumoniae
19%
Biofilm Growth
19%
Bacterial Colonization
19%
Secondary Infection
19%
Resistance Phenotypes
19%
S. Pneumoniae
19%
Intensive Care Patients
19%
Chlorhexidine
19%
Clinical Outcomes
19%
Double-lumen Catheter
19%
Antibacterial Susceptibility
19%
Fecal Carriage
19%
Immunology and Microbiology
Antimicrobial Resistance
46%
Escherichia coli
44%
Sputum
39%
Whole Genome Sequencing
39%
Enterobacteriaceae
19%
Biofilm
19%
Bacterium Culture
19%
Pneumococcus
19%
Nontypeable Haemophilus Influenzae
19%
Chlorhexidine
19%
Microbiology
19%
Bacterial Colonization
19%
Human Immunodeficiency Virus
19%
Mycobacterium Tuberculosis
19%
Gram-Negative Bacteria
19%
Haemophilus influenzae
19%
Streptococcus pneumonia
19%
Normal Human
16%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
14%
Pneumococcal Vaccine
13%
DNA Sequence
11%
Infectious Agent
10%
Genetic Variability
9%
Klebsiella pneumoniae
9%
Viable Cell Count
8%
Meningitis
8%
Serotype
8%
Middlebrook 7H10 Agar
6%
Mycobacteria
6%
Transfer RNA
6%
Illumina Dye Sequencing
6%
RNA Gene
6%
DNA Base Composition
6%
Bacterial Growth
5%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
30%
Escherichia coli
29%
Antimicrobial Resistance
29%
Gram Negative Bacterium
26%
Antiinfective Agent
25%
Quinolone Derivative
22%
Cross-Sectional Study
21%
Salmonella enterica
19%
Glutamine
19%
Apoptosis Inducing Factor
19%
Retrospective Study
19%
Urinary Tract Infection
19%
Secondary Infection
19%
Ventilator Associated Pneumonia
19%
Levofloxacin
19%
Cisplatin
19%
Coronavirinae
19%
Noradrenalin
19%
Nontypeable Haemophilus Influenzae
19%
Haemophilus influenzae
19%
Ciprofloxacin
14%
Acinetobacter Baumannii
11%
Antibiotics
11%
Typhoid Fever
9%
Ampicillin
8%
Klebsiella pneumoniae
8%
Intraperitoneal Injection
5%
Nephrotoxicity
5%
Pseudomonas aeruginosa
5%
Bacterial Infection
5%